+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Migraine - Pipeline Insight, 2025 - Product Thumbnail Image

Migraine - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitochondrial Myopathies- Pipeline Insight, 2025 - Product Thumbnail Image

Mitochondrial Myopathies- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitral Valve Insufficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Mitral Valve Insufficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Acute Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Acute Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Inflammatory Acne Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Inflammatory Acne Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025 - Product Thumbnail Image

Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis I - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis I - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis II - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis II - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2025 - Product Thumbnail Image

Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Multiple System Atrophy- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple System Atrophy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Muscle Spasticity - Pipeline Insight, 2025 - Product Thumbnail Image

Muscle Spasticity - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Musculoskeletal Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Musculoskeletal Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epstein Barr Virus (EBV) - Pipeline Insight, 2025 - Product Thumbnail Image

Epstein Barr Virus (EBV) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Narcotic Overdose - Pipeline Insight, 2025 - Product Thumbnail Image

Narcotic Overdose - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more